In Silico, In Vitro, and Ex Vivo Biological Activity of Some Novel Mebeverine Precursors
Irritable bowel syndrome (IBS) is a functional gastroenterological disorder with complex pathogenesis and multifaceted therapy approaches, aimed at alleviating clinical symptoms and improving the life quality of patients. Its treatment includes dietary changes and drugs from various pharmacological...
Main Authors: | Miglena Milusheva, Vera Gledacheva, Iliyana Stefanova, Mina Pencheva, Rositsa Mihaylova, Yulian Tumbarski, Paraskev Nedialkov, Emiliya Cherneva, Mina Todorova, Stoyanka Nikolova |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/11/2/605 |
Similar Items
-
Spasmolytic Activity and Anti-Inflammatory Effect of Novel Mebeverine Derivatives
by: Mihaela Stoyanova, et al.
Published: (2024-10-01) -
Drug-Loaded Silver Nanoparticles—A Tool for Delivery of a Mebeverine Precursor in Inflammatory Bowel Diseases Treatment
by: Mina Todorova, et al.
Published: (2023-05-01) -
2-Amino-<i>N</i>-Phenethylbenzamides for Irritable Bowel Syndrome Treatment
by: Miglena Milusheva, et al.
Published: (2024-07-01) -
Pharmacokinetic study of prolonged release capsules of mebeverine
by: A. L. Khokhlov, et al.
Published: (2017-02-01) -
Novel Anthranilic Acid Hybrids—An Alternative Weapon against Inflammatory Diseases
by: Miglena Milusheva, et al.
Published: (2023-11-01)